TUDOR INVESTMENT CORP ET AL - PHARMERICA CORP ownership

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of PHARMERICA CORP
ValueSharesWeighting
Q1 2017$201,000
-2.9%
8,602
+4.7%
0.01%
+20.0%
Q4 2016$207,000
-72.3%
8,213
-75.7%
0.01%
-73.7%
Q1 2016$747,000
-10.2%
33,800
+42.2%
0.02%
-17.4%
Q4 2015$832,000
+160.8%
23,766
+112.3%
0.02%
+109.1%
Q3 2015$319,000
-52.8%
11,195
-44.8%
0.01%
-45.0%
Q2 2015$676,000
+56.1%
20,298
+32.1%
0.02%
+42.9%
Q1 2015$433,000
-35.5%
15,368
-52.6%
0.01%
-39.1%
Q4 2014$671,000
+3.7%
32,400
+22.3%
0.02%0.0%
Q3 2014$647,000
+19.6%
26,500
+40.1%
0.02%
+9.5%
Q2 2014$541,000
-6.6%
18,910
-8.6%
0.02%
-16.0%
Q1 2014$579,000
+16.0%
20,699
-10.8%
0.02%
+4.2%
Q4 2013$499,000
-6.4%
23,213
-42.3%
0.02%
+9.1%
Q3 2013$533,000
-6.0%
40,200
-1.7%
0.02%
-48.8%
Q2 2013$567,00040,9000.04%
Other shareholders

There were no reported owners of PHARMERICA CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of PHARMERICA CORP shareholders